Treatment of severe covid-19 with interleukin 6 receptor inhibition
BMJ Med
.
2022 Mar 2;1(1):e000144.
doi: 10.1136/bmjmed-2022-000144.
eCollection 2022.
Authors
Skanda Rajasundaram
1
,
Stephen Burgess
2
,
Dipender Gill
3
Affiliations
1
University of Oxford, Oxford, UK.
2
University of Cambridge, Cambridge, UK.
3
Imperial College London, London, UK.
PMID:
36936584
PMCID:
PMC9978669
DOI:
10.1136/bmjmed-2022-000144
No abstract available
Publication types
Editorial
Grants and funding
MC_UU_00002/7/MRC_/Medical Research Council/United Kingdom